Ingelheim, Germany (ots/PRNewswire) – – Results From Linagliptin Study in Type 2 Diabetes Patients Who Were Inadequately Controlled on Metformin Therapy Alone, Presented at Major Diabetes Meeting Study results presented for the first time in the scientific sessions of this year’s American Diabetes Association Annual Meeting (ADA) show clinically relevant and statistically significant reductions in [...]
Tag Archive > Glycaemic Control
New NICE Guideline for Type 2 Diabetes Recognises Benefits From Newer Agents for Blood Glucose Control
London (ots/PRNewswire) – – For Healthcare and Pharmaceutical Correspondents Only – NICE Recommends Considering DPP-4 Inhibitors as a Second Line Treatment Option in Appropriate Patients Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from the National Institute for Health and Clinical Excellence (NICE) in the [...]
